IRADIMED CORP — Director's Dealing 2020

Feb 20, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2020-02-18

Reporting Person: ALLEN MONTY K (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-18	Common Stock	M	2136	$7.1	Acquired	23419	Direct
2020-02-18	Common Stock	S	2136	$26.12	Disposed	21283	Direct
2020-02-19	Common Stock	M	2864	$7.1	Acquired	24147	Direct
2020-02-19	Common Stock	S	2864	$26	Disposed	21283	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-18	Stock Option (Right to Buy)	$7.1	M	2136	Acquired		Common Stock (2136)	Direct
2020-02-19	Stock Option (Right to Buy)	$7.1	M	2864	Acquired		Common Stock (2864)	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $26.00 to $26.35. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2: This transaction was executed in multiple trades at prices ranging from $26.00 to $26.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: This option, representing a right to purchase a total of 10,000 shares, was granted on 9/29/2014 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date.